Interleukin-10 (IL-10) is a key anti-inflammatory cytokine that helps regulate the immune system and prevent excessive inflammation. It is released by immune cells to calm inflammatory responses and protect tissues after the immune system has been activated by infection, injury, or stress. IL-10 testing provides insight into the body’s immune regulation and recovery processes. Although IL-10 does not diagnose specific diseases on its own, it is often measured alongside other inflammatory markers to understand overall immune activity and balance. Equivocal or borderline IL-10 results can occur when levels are near the reference cutoff. This may mean that immune-regulatory activity is shifting or that the body is in a transitional phase — such as early recovery from infection, low-grade inflammation, or stress-related immune modulation. In these cases, clinical context and additional markers (such as CRP, IL-6, TNF-α, and complete immune panels) help clarify the significance of the result. This marker is especially relevant when assessing chronic inflammation, immune-related conditions, or the body's response after acute immune activation.

Interleukin-2 Receptor Alpha Chain (IL-2Ra), also known as CD25, is a protein expressed on the surface of immune cells, such as activated T-cells, B-cells, and natural killer (NK) cells. When it is shed from the surface of these cells, it circulates in the blood as soluble IL-2 receptor alpha (sIL-2Ra). Measuring sIL-2Ra levels provides insights into immune system activity and inflammation. Why Is This IL-2Ra Important? sIL-2Ra plays a critical role in the regulation of the immune response. It binds to interleukin-2 (IL-2), a key cytokine for T-cell growth and immune function. Elevated levels of sIL-2Ra are associated with immune system activation and are often seen in various inflammatory and autoimmune conditions, cancers, and infectious diseases. Normal and Elevated Levels Normal Range: Reference ranges can vary by laboratory but are typically around 532 – 1891 pg/mL. Elevated Levels: Increased sIL-2Ra indicates immune activation and may suggest conditions such as: Autoimmune diseases (e.g., rheumatoid arthritis, lupus, multiple sclerosis) Chronic infections (e.g., Epstein-Barr virus, tuberculosis) Lymphoproliferative disorders (e.g., Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, leukemia) Transplant rejection – Elevated sIL-2Ra is a marker for organ rejection in transplant recipients. Cytokine release syndrome (CRS) in severe inflammatory states. Clinical Use and Interpretation Disease Monitoring: sIL-2Ra is often used to monitor disease progression or treatment response in patients with inflammatory or autoimmune disorders. Differential Diagnosis: Helps differentiate between active and quiescent phases of autoimmune diseases. Cancer Prognosis: In some lymphomas and leukemias, high levels of sIL-2Ra correlate with poor prognosis. Symptoms and Conditions Related to Elevated sIL-2Ra Patients with elevated soluble IL-2 receptor levels may experience: Fatigue and fever Joint pain and swelling (in autoimmune diseases) Unexplained weight loss (in lymphoproliferative disorders) Chronic infections that are difficult to clear Reducing Elevated IL-2Ra Levels Treatment depends on addressing the underlying cause. For example: Autoimmune conditions: Immunosuppressive therapy may reduce inflammation and sIL-2Ra levels. Chronic infections: Proper antimicrobial treatment can help normalize levels. Cancer: Chemotherapy, radiation, or targeted therapy for lymphoma or leukemia may reduce sIL-2Ra.

Interleukin 2 (IL-2) is a pleiotropic (=having multiple effects from a single gene) cytokine produced primarily by mitogen- or antigen- activated T lymphocytes. Interleukin 2 plays a role in promoting the clonal expansion of antigen-specific cytotoxic and suppressor T cells. In vitro studies suggest that Interleukin 2 may also be produced by dendritic cells and certain lymphoma cell lines. In addition, IInterleukin 2 has been shown to mediate multiple immune responses on a variety of cell types. Interleukin 2 stimulates the proliferation of thymocytes; stimulates the proliferation and differentiation of activated B cells; promotes the growth, differentiation, and cytocidal activity of monocytes; induces the growth of natural killer cells and stimulates cytokine production by these cells, as well as enhancing the cytolytic activity of these cells; enhances the production of lymphocyte-activated killer (LAK) cells; and induces the proliferation and differentiation of oligodendrocytes. References: - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728644/

Interleukin-6 is involved in inflammation and infection responses and also in the regulation of metabolic, regenerative, and neural processes.